PHASE I STUDY OF CABAZITAXEL IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID TUMORS: A POETIC GROUP STUDY

被引：0
|
作者：
Manley, P. [1 ]
Trippett, T. [2 ]
Smith, A. [3 ]
Macy, M. [4 ]
Leary, S. [5 ,6 ]
Boklan, J. [7 ]
Cohen, K. [8 ]
Shen, L. [9 ]
Herzog, C. [10 ]
Veyrat-Follet, C. [11 ]
Zhang, J. [12 ]
Chi, S. [1 ]
机构：
[1] Dana Farber Canc Inst, Pediat Oncol, Boston, MA 02115 USA
[2] Mem Sloan Kettering Canc Ctr, Pediat Hematol Oncol, New York, NY 10021 USA
[3] Arnold Palmer Med Ctr, Pediat Hematol Oncol, Orlando, FL USA
[4] Univ Colorado, Childrens Hosp Colorado, Pediat Hematol Oncol, Aurora, CO USA
[5] Seattle Childrens Univ Washington, Seattle, WA USA
[6] Fred Hutchinson Canc Res Ctr, Pediat Hematol Oncol, Seattle, WA 98104 USA
[7] Phoenix Childrens Hosp, Pediat Hematol Oncol, Phoenix, AZ USA
[8] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Pediat Hematol Oncol, Baltimore, MD USA
[9] Sanofi US, Sanofi Oncol, Bridgewater, MA USA
[10] Univ Texas MD Anderson Canc Ctr, Pediat Hematol Oncol, Houston, TX 77030 USA
[11] Sanofi, Drug Disposit Disposit Safety & Anim Res Dept, Vitry Sur Seine, France
[12] Sanofi, Sanofi Oncol, Cambridge, MA USA
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-049
引用
收藏
页码：S157 / S158
页数：2
相关论文
共 50 条
  • [41] Phase I Study of Bevacizumab Plus Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors
    Okada, Keiko
    Yamasaki, Kai
    Tanaka, Chika
    Fujisaki, Hiroyuki
    Osugi, Yuko
    Hara, Junichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (11) : 1073 - 1079
  • [42] Phase I study of vaccine therapy with a cocktail of peptides for pediatric patients with refractory solid tumors
    Akazawa, Yu
    Hosono, Ako
    Yoshikawa, Toshiaki
    Kaneda, Hide
    Hara, Junichi
    Kinoshita, Yoshiaki
    Kohashi, Kenichi
    Manabe, Atsushi
    Shioda, Yoko
    Shoda, Kayoko
    Shimomura, Manami
    Mizuno, Shoichi
    Nakamoto, Yasunari
    Nakatsura, Tetsuya
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [43] Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study
    Trippett, Tanya
    Toledano, Helen
    Hewson, Quentin Campbell
    Verschuur, Arnauld
    Langevin, Anne-Marie
    Aerts, Isabelle
    Howell, Lisa
    Gallego, Soledad
    Rossig, Claudia
    Smith, Amy
    Patel, Darshak
    Pereira, Leonardo R.
    Cheeti, Sravanthi
    Musib, Luna
    Hutchinson, Katherine E.
    Devlin, Clare
    Bernardi, Ronald
    Geoerger, Birgit
    TARGETED ONCOLOGY, 2022, 17 (03) : 283 - 293
  • [44] Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study
    Tanya Trippett
    Helen Toledano
    Quentin Campbell Hewson
    Arnauld Verschuur
    Anne-Marie Langevin
    Isabelle Aerts
    Lisa Howell
    Soledad Gallego
    Claudia Rossig
    Amy Smith
    Darshak Patel
    Leonardo R. Pereira
    Sravanthi Cheeti
    Luna Musib
    Katherine E. Hutchinson
    Clare Devlin
    Ronald Bernardi
    Birgit Geoerger
    Targeted Oncology, 2022, 17 : 283 - 293
  • [45] A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors
    Cash, Thomas
    Jonus, Hunter C.
    Tsvetkova, Maya
    Beumer, Jan H.
    Sadanand, Arhanti
    Lee, Jasmine Y. Y.
    Henry, Curtis J.
    Aguilera, Dolly
    Harvey, R. Donald
    Goldsmith, Kelly C.
    PEDIATRIC BLOOD & CANCER, 2023, 70 (08)
  • [46] A Phase I Study of Vincristine, Irinotecan, Temozolomide and Bevacizumab (Vitb) in Pediatric Patients with Relapsed Solid Tumors
    Venkatramani, Rajkumar
    Malogolowkin, Marcio
    Davidson, Tom B.
    May, William
    Sposto, Richard
    Mascarenhas, Leo
    PLOS ONE, 2013, 8 (07):
  • [47] Phase I dose-finding study for melatonin in pediatric oncology patients with relapsed solid tumors
    Johnston, Donna L.
    Zupanec, Susan
    Nicksy, Darcy
    Morgenstern, Daniel
    Narendran, Aru
    Deyell, Rebecca J.
    Samson, Yvan
    Wu, Bing
    Baruchel, Sylvain
    PEDIATRIC BLOOD & CANCER, 2019, 66 (06)
  • [48] A PHASE I STUDY OF VINCRISTINE, IRNIOTECAN, TEMOZOLOMIDE AND BEVACIZUMAB (VITB) IN PEDIATRIC PATIENTS WITH RELAPSED SOLID TUMORS
    Venkatramani, Rajkumar
    Malogolowkin, Marcio
    Davidson, Tom
    May, William
    Sposto, Richard
    Mascarenhas, Leo
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S5 - S5
  • [49] A PHASE-I STUDY OF SULOFENUR IN REFRACTORY PEDIATRIC MALIGNANT SOLID TUMORS
    PRATT, CB
    BOWMAN, LC
    MARINA, N
    PAPPO, A
    AVERY, L
    LUO, XL
    MEYER, WH
    INVESTIGATIONAL NEW DRUGS, 1995, 13 (01) : 63 - 66
  • [50] A PHASE I STUDY OF VINBLASTINE AND SIROLIMUS IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING CNS TUMORS
    Marzouki, Monia
    Bartels, Ute
    Gammon, Janet
    Bergendahl, Genevieve
    Yankanah, Rosanna
    Wu, Bing
    Samson, Yvan
    Sholler, Giselle
    Irwin, Meredith S.
    Baruchel, Sylvain
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1091 - 1091
12345